Cambridge Investment Research Advisors’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.67M Sell
84,602
-1,925
-2% -$120K 0.01% 968
2026
Q1
$5.33M Sell
86,527
-62,221
-42% -$4.02M 0.01% 930
2025
Q4
$9.68M Buy
148,748
+43,130
+41% +$2.72M 0.03% 597
2025
Q3
$6.2M Sell
105,618
-24,457
-19% -$1.39M 0.02% 789
2025
Q2
$7.35M Buy
130,075
+3,394
+3% +$191K 0.02% 675
2025
Q1
$7.71M Buy
126,681
+51
+0% +$3.12K 0.03% 603
2024
Q4
$7.38M Sell
126,630
-20,477
-14% -$1.27M 0.02% 615
2024
Q3
$9.56M Sell
147,107
-4,664
-3% -$298K 0.03% 517
2024
Q2
$9.3M Sell
151,771
-1,709
-1% -$103K 0.03% 498
2024
Q1
$9.5M Buy
153,480
+11,525
+8% +$693K 0.04% 479
2023
Q4
$8.13M Sell
141,955
-60,140
-30% -$3.27M 0.03% 487
2023
Q3
$10.9M Sell
202,095
-37,105
-16% -$2.07M 0.05% 353
2023
Q2
$13.4M Buy
239,200
+24,050
+11% +$1.34M 0.06% 306
2023
Q1
$11.8M Sell
215,150
-53,275
-20% -$2.92M 0.06% 330
2022
Q4
$15.2M Buy
268,425
+13,710
+5% +$757K 0.08% 251
2022
Q3
$12.9M Buy
254,715
+48,230
+23% +$2.61M 0.07% 265
2022
Q2
$11.1M Buy
206,485
+86,320
+72% +$4.74M 0.06% 308
2022
Q1
$6.94M Buy
120,165
+8,325
+7% +$465K 0.03% 507
2021
Q4
$6.72M Buy
111,840
+2,115
+2% +$121K 0.03% 532
2021
Q3
$6.05M Buy
109,725
+10,755
+11% +$615K 0.03% 531
2021
Q2
$5.4M Buy
98,970
+9,065
+10% +$480K 0.03% 581
2021
Q1
$4.54M Sell
89,905
-55
-0.1% -$2.77K 0.02% 598
2020
Q4
$4.42M Buy
89,960
+6,210
+7% +$293K 0.03% 576
2020
Q3
$3.81M Sell
83,750
-21,390
-20% -$968K 0.03% 553
2020
Q2
$4.53M Buy
105,140
+31,470
+43% +$1.33M 0.03% 480
2020
Q1
$2.77M Sell
73,670
-98,380
-57% -$4.05M 0.03% 540
2019
Q4
$7.42M Buy
172,050
+95,365
+124% +$3.85M 0.06% 328
2019
Q3
$2.9M Sell
76,685
-29,660
-28% -$1.14M 0.03% 614
2019
Q2
$4.15M Buy
106,345
+22,820
+27% +$864K 0.04% 465
2019
Q1
$3.24M Sell
83,525
-67,635
-45% -$2.57M 0.03% 532
2018
Q4
$5.47M Sell
151,160
-5,525
-4% -$212K 0.06% 295
2018
Q3
$6.36M Buy
156,685
+92,205
+143% +$3.56M 0.06% 308
2018
Q2
$2.3M Sell
64,480
-790
-1% -$27.9K 0.02% 603
2018
Q1
$2.25M Sell
65,270
-14,845
-19% -$534K 0.03% 594
2017
Q4
$2.79M Sell
80,115
-147,250
-65% -$5.11M 0.03% 480
2017
Q3
$7.82M Buy
227,365
+169,935
+296% +$5.73M 0.11% 179
2017
Q2
$1.91M Sell
57,430
-115,170
-67% -$3.68M 0.03% 540
2017
Q1
$5.38M Buy
172,600
+124,100
+256% +$3.79M 0.09% 212
2016
Q4
$1.4M Sell
48,500
-17,490
-27% -$507K 0.03% 544
2016
Q3
$1.98M Buy
65,990
+10,730
+19% +$328K 0.04% 438
2016
Q2
$1.64M Buy
55,260
+1,560
+3% +$45.6K 0.03% 424
2016
Q1
$1.51M Sell
53,700
-10,315
-16% -$286K 0.03% 422
2015
Q4
$1.92M Buy
64,015
+2,615
+4% +$77.7K 0.05% 363
2015
Q3
$1.72M Sell
61,400
-99,335
-62% -$3.09M 0.05% 344
2015
Q2
$5.1M Buy
160,735
+55,080
+52% +$1.73M 0.14% 148
2015
Q1
$3.26M Buy
105,655
+8,490
+9% +$256K 0.09% 216
2014
Q4
$2.8M Buy
97,165
+25,420
+35% +$716K 0.09% 224
2014
Q3
$1.93M Buy
71,745
+32,960
+85% +$868K 0.06% 331
2014
Q2
$995K Sell
38,785
-24,955
-39% -$616K 0.03% 458
2014
Q1
$1.57M Buy
63,740
+9,890
+18% +$241K 0.06% 315
2013
Q4
$1.25M Buy
53,850
+15,150
+39% +$341K 0.05% 332
2013
Q3
$828K Sell
38,700
-2,350
-6% -$49.8K 0.04% 427
2013
Q2
$823K Buy
+41,050
New +$826K 0.04% 368

Other funds holding IYH

Cambridge Investment Research Advisors's IYH Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its iShares US Healthcare ETF (IYH) stake by 2.2% in Q2 2026, selling an estimated $120K and leaving 84,602 shares worth $5.67M. The position accounts for 0.01% of the portfolio, ranked #968.

Cambridge Investment Research Advisors first reported a position in IYH in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.2M in Q4 2022. 529 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Cambridge Investment Research Advisors held 84,602 shares of iShares US Healthcare ETF worth $5.67M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 1,925 iShares US Healthcare ETF shares in Q2 2026, an estimated $120K.
  • iShares US Healthcare ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #968 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares US Healthcare ETF in Q2 2013 and has held it in 53 quarters since.
  • Cambridge Investment Research Advisors's iShares US Healthcare ETF position peaked at $15.2M in Q4 2022.
  • 529 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.